The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISA 2022 | The clinical importance of left atrial infiltration in ATTR and cardiac AL amyloidosis
Marianna Fontana, MD, PhD, University College London, London, UK, comments on the clinical importance of left atrial infiltration in patients with cardiac AL or ATTR amyloidosis, highlighting the need to guide treatment decisions based on the presence or absence of mechanical contraction. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Consultancy for: Alnylam, Ionis, Intellia, Novonordisk, Janssen, Caelum, Pfizer, Bridgbio, Eidos
